AutologousCD22 Chimeric Antigen Receptor (CAR)T Cells in w/Recurrent/Refractory B Cell Lymphomas

Clinical trial NCT06340737 · RECRUITING

Trial details

NCT number: NCT06340737
Sponsor: Stanford University
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Follicular Lymphoma Mantle Cell Lymphoma Hairy Cell Leukemia Lymphoplasmacytic Lymphoma Burkitt Lymphoma Marginal Zone Lymphoma Waldenstrom Macroglobulinemia Large B-cell Lymphoma

Start date: 2024-03-29
Primary completion: 2031-04-01
Enrollment: 148

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.